Low over-expression of TNFα in the mouse heart increases contractile performance via TNFR1

Journal of Cellular Biochemistry

Volumn 105, Issue 1, 2008, Pages 99-107

  Pinz, Ilka ^a,b   Wax, Stephen D ^a   Anderson, Paul ^a   Ingwall, Joanne S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Maine Medical Center Research Institute   (United States)

Author keywords

Ca2+ sensitivity; Contractility; Myocardial contraction; TNF

Indexed keywords

CALCIUM ION; CALMODULIN; CYTOKINE; DEOXYGLUCOSE; MESSENGER RNA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; CALCIUM; POLYADENYLIC ACID BINDING PROTEIN; TNFRSF1A PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL TISSUE; ARTICLE; HEART CONTRACTION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; ISOLATED HEART; MALE; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; METABOLISM; MOUSE MUTANT; MUSCLE CONTRACTION; REPERFUSION INJURY;

MURINAE; MUS;

ANIMALS; CALCIUM; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE CONTRACTION; MYOCARDIUM; POLY(A)-BINDING PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; REPERFUSION INJURY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51849118111     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21798     Document Type: Article

References (28)

1. Abel ED, Kaulbach HC, Tian R, Hopkins JC, Duffy J, Doetschman T, Minnemann T, Boers ME, Hadro E, Oberste-Berghaus C, Quist W, Lowell BB, Ingwall JS, Kahn BB. 1999. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest 104:1703-1714.
2. Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS, Eberli FR. 2000. ATP synthesis during low-flow ischemia: Influence of increased glycolytic substrate. Circulation 101:2090-2096.
3. Chen G, Goeddel DV. 2002. TNF-R1 signaling: A beautiful pathway. Science 296:1634-1635.
4. Chu G, Luo W, Slack JP, Tilgmann C, Sweet WE, Spindler M, Saupe KW, Boivin GP, Moravec CS, Matlib MA, Grupp IL, Ingwall JS, Kranias EG. 1996. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ Res 79:1064-1076.
5. Evans JA, Eisenberg E. 1989. Intermediate oxygen exchange catalyzed by the actin-activated skeletal myosin adenosinetriphosphatase. Biochemistry 28:7741-7747.
6. Haudek SB, Taffet GE, Schneider MD, Mann DL. 2007. TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest 117:2692-2701.
7. Hotamisligil GS. 2003. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27(Suppl 3):S53-S55.
8. Hunter I, Cobban HJ, Vandenabeele P, MacEwan DJ, Nixon GF. 2003. Tumor necrosis factor-alpha-induced activation of RhoA in airway smooth muscle cells: Role in the Ca2+ sensitization of myosin light chain20 phosphorylation. Mol Pharmacol 63:714-721.
9. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. 1995a. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96:1042-1052.
10. Kapadia S, Torre-Amione G, Yokoyama T, Mann DL. 1995b. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro. Am J Physiol 268:H517-H525.
11. Kurrelmeyer KM, Michael LH, Baumgarten G, Taffet GE, Peschon JJ, Sivasubramanian N, Entman ML, Mann DL. 2000. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA 97:5456-5461.
12. Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, Sack MN. 2002. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol 34:509-518.
13. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY, Goeddel DV. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88:2830-2834.
14. Lopez de Silanes I, Galban S, Martindale JL, Yang X, Mazan-Mamczarz K, Indig FE, Falco G, Zhan M, Gorospe M. 2005. Identification and functional outcome of mRNAs associated with RNA-binding protein TIA-1. Mol Cell Biol 25:9520-9531.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
16. MacEwan DJ. 2002. TNF receptor subtype signaling: Differences and cellular consequences. Cellular Sign 14:477-492.
17. Mann DL. 2003. Stress-activated cytokines and the heart: From adaptation to maladaptation. Annu Rev Physiol 65:81-101.
18. Parris JR, Cobban HJ, Littlejohn AF, MacEwan DJ, Nixon GF. 1999. Tumour necrosis factor-alpha activates a calcium sensitization pathway in guinea-pig bronchial smooth muscle. J Physiol 518(Pt 2):561-569.
19. Phillips K, Kedersha N, Shen L, Blackshear PJ, Anderson P. 2004. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proc Natl Acad Sci USA 101:2011-2016.
20. Piecyk M, Wax S, Beck AR, Kedersha N, Gupta M, Maritim B, Chen S, Gueydan C, Kruys V, Streuli M, Anderson P. 2000. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J 19:4154-4163.
21. Pollock J, McFarlane SM, Connell MC, Zehavi U, Vandenabeele P, MacEwan DJ, Scott RH. 2002. TNF-alpha receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones. Neuropharmacology 42:93-106.
22. Rathi SS, Xu YJ, Dhalla NS. 2002. Mechanism of cardioprotective action of TNF alpha in isolated rat heart. Exp Clin Cardiol 7:146-150.
23. Saraste A, Voipio-Pulkki LM, Parvinen M, Pulkki K. 1997. Apoptosis in the heart. N Engl J Med 336:1025-1026; author reply1026.
24. Saupe KW, Spindler M, Tian R, Ingwall JS. 1998. Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ Res 82:898-907.
25. Scott RH, Pollock J, Ayar A, Thatcher NM, Zehavi U. 2000. Synthesis and use of caged sphingolipids. Methods Enzymol 312:387-400.
26. Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, DeMayo FJ, Spinale FG, Mann DL. 2001. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104:826-831.
27. Van Rooyen J, McCarthy J, Opie LH. 2002. Increased glycolysis during ischaemia mediates the protective effect of glucose and insulin in the isolated rat heart despite the presence of cardiodepressant exogenous substrates. Cardiovasc J S Afr 13:103-109.
28. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. 1993. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92:2303-2312.